Ascendis Pharma
ASND
$136.93
Share price
-4.37%
Change (1 day)
74.74%
Change (1 year)
Categories
Earnings for Ascendis Pharma (ASND)
Earnings in 2023 (TTM): -$0.46 B
According to Ascendis Pharma 's latest financial reports the company's current earnings (TTM) are -$0.46 B. In 2022 the company made an earning of -$0.53 B a decrease over its 2021 earnings that were of -$0.43 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Ascendis Pharma from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.46 B | -13.72% |
| 2022 | -$0.53 B | 23.17% |
| 2021 | -$0.43 B | -10.38% |
| 2020 | -$0.48 B | 104.57% |
| 2019 | -$0.24 B | 61.23% |
| 2018 | -$0.15 B | 0.79% |
| 2017 | -$0.15 B | 90.02% |
| 2016 | -$75.84 M | 103.21% |
| 2015 | -$37.33 M | 186.25% |
| 2014 | -$13.04 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | -$51.27 M | -88.76% | 🇺🇸 USA |
 Affimed
AFMD | -$0.12 B | -74.82% | 🇩🇪 Germany |
 Advaxis ADXS | -$33.55 M | -92.65% | 🇺🇸 USA |